Adrian McKemey leads the IQVIA Enterprise Transformation Group with a focus on leveraging direct from patient data to transform the development and care model. Key initiatives include harnessing data for patient foundations (including MMRF, FLF, MDA, KPMA) and government (including CIRM, NMDP, NIH BESPOKE) to democratize access to cell and gene therapies. He serves on the executive committee of the Alliance for Regenerative Medicine Foundation and the advisory board of Caring Cross. He holds a PhD in high energy nuclear particle physics from London University.
